Plethlogics was formed to commercialize technologies relating to the electronic capture of pulsus paradoxus as a critical, objective index of cardiac and pulmonary disease severity. It is the Companyâs goal to reestablish pulsus paradoxus, through the integration of Pulse+ technology in patient monitors, as a critical, first-line data point used by physicians in assessing the health of patients --- joining pulse rate, blood pressure, temperature, respiration and pulse oximetry as a vital sig
